PCOS Explained: 7 Warning Signs Women Often Miss

📅 Published: 31 August 2025

Introduction

Polycystic Ovary Syndrome (PCOS) is one of the most common reproductive disorders affecting women worldwide, with prevalence estimates ranging from 4% to 20%. Symptoms often appear between the ages of 18 and 39, yet many women remain undiagnosed for years due to delayed recognition and treatment.

Women with PCOS may experience excessive hair growth, acne, irregular menstrual cycles, and elevated insulin levels. Metabolic issues, such as insulin resistance and obesity, affect a large proportion of patients. Beyond physical symptoms, PCOS can also impact mental health, causing anxiety, depression, and reduced quality of life. Fertility challenges are also common, with many women struggling to conceive or experiencing early pregnancy loss. For readers who want more detailed statistics and global insights, the World Health Organization’s fact sheet on PCOS provides an excellent overview.

Early detection of PCOS is crucial because it helps manage associated health risks, including diabetes, hypertension, sleep apnea, and mental health disorders. Although the exact cause of PCOS remains unclear, research suggests that a combination of genetic and environmental factors contributes to its development. Understanding these underlying mechanisms can pave the way for better treatments and improved patient outcomes.

Diagnostic Criteria for PCOS

Diagnosing PCOS involves a combination of clinical signs, biochemical tests, and imaging findings. Over the years, several criteria have been developed to ensure accurate identification of this complex syndrome.

Rotterdam Criteria (2003)

The Rotterdam Criteria, established by experts from the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM), require the presence of any two of the following three features for a PCOS diagnosis:

1. Hyperandrogenism

  • Can be clinical (hirsutism, acne, androgenic alopecia)
  • Or biochemical (elevated testosterone, androstenedione, DHEAS)

2. Ovulatory Dysfunction

  • Oligomenorrhea (infrequent menstrual cycles)
  • Amenorrhea (absence of menstruation)
  • A common cause of infertility

3. Polycystic Ovarian Morphology (PCOM)

  • Ultrasound shows ≥12 follicles (2–9 mm) or ovarian volume >10 cm³
  • Classic “string of pearls” appearance on imaging

Androgen Excess Society (AES) Criteria (2006)

The AES criteria emphasize hyperandrogenism as the central feature, while still recognizing the importance of ovarian morphology in diagnosing PCOS.

NIH 2012 Workshop and PCOS Sub-Phenotypes

To resolve clinical confusion from multiple classification systems, the NIH held a workshop in 2012, reaffirming the Rotterdam Criteria and introducing sub-phenotypes:

1. Ovulatory Dysfunction and Androgen Excess

2. Polycystic Ovarian Morphology (PCOM) and Androgen Excess

3. PCOM and Ovulatory Dysfunction

4. PCOM, Ovulatory Dysfunction, and Androgen Excess

These sub-phenotypes help clinicians tailor diagnosis and treatment according to the specific presentation of PCOS in each patient.

Key Diagnostic Features

Biochemical Hyperandrogenism

Biochemical hyperandrogenism refers to elevated levels of male hormones, such as testosterone, androstenedione, and DHEAS. Laboratory tests are essential to confirm hyperandrogenism, as abnormal androgen levels are a key hallmark of PCOS.

Clinical Hyperandrogenism

Clinical hyperandrogenism is identified through physical symptoms, including:

  • Hirsutism (excessive hair growth in a male-pattern distribution)
  • Acne
  • Androgenic alopecia (thinning hair or male-pattern baldness)

The Ferriman-Gallwey scoring system is commonly used to quantify the severity of hirsutism, helping standardize clinical evaluation.

Ovulatory Dysfunction

Ovulatory dysfunction is a major feature of PCOS. Women may experience:

  • Oligomenorrhea (infrequent menstrual cycles)
  • Amenorrhea (absence of menstruation)

This irregular ovulation is a common cause of infertility in women with PCOS.

Polycystic Ovarian Morphology

Polycystic ovaries can be detected via ultrasound, typically showing:

  • ≥12 small follicles measuring 2–9 mm in diameter
  • Ovarian volume >10 cm³

This creates the classic “string of pearls” appearance, where multiple small follicles line the periphery of the ovary like a necklace.

Pathophysiology of PCOS

Polycystic Ovary Syndrome (PCOS) is a multifactorial endocrine disorder involving hormonal, ovarian, metabolic, and systemic dysfunctions. The pathophysiology is complex and interlinked, which is why symptoms vary widely among women. Understanding these mechanisms is critical for effective management and treatment.

Tissue Changes and Histopathology

PCOS affects the ovaries structurally and histologically, leading to abnormal follicle development and androgen production:

1. Increased Small Antral Follicles

  • Women with PCOS typically have numerous small antral follicles (2–9 mm) that fail to mature.
  • Follicular arrest occurs due to hormonal imbalance, particularly excess androgens and insufficient FSH stimulation.
  • These small follicles accumulate in the ovary, contributing to the polycystic appearance seen on ultrasound.

2. Thickened Ovarian Cortex

  • The ovarian cortex becomes fibrotic and thickened, impairing normal ovulation.
  • Thickened stroma increases androgen production, further disrupting follicle maturation.

3. Theca Cell Hyperplasia and Stromal Hyperthecosis

  • Theca cells in the ovarian stroma proliferate, producing excess androgens (testosterone, androstenedione).
  • Hyperthecosis leads to enlarged ovarian stroma with increased vascularity, creating a microenvironment that favors androgen excess.

Hormonal Feedback Disruption

Hormonal imbalances are central to PCOS, primarily involving the hypothalamic-pituitary-ovarian (HPO) axis.

1. HPO Axis Dysregulation

  • Abnormal GnRH pulsatility favors LH secretion over FSH.
  • Higher LH stimulates theca cells, causing excess androgen production.

2. Elevated LH and Hyperandrogenism

  • High androgen levels inhibit granulosa cell function, preventing follicle maturation and leading to anovulation.
  • Clinical manifestations include hirsutism, acne, and androgenic alopecia.

3. Insulin Resistance and SHBG Reduction

  • Insulin resistance, a common feature of PCOS, reduces sex hormone-binding globulin (SHBG).
  • Lower SHBG increases free circulating androgens, worsening hyperandrogenism and creating a vicious cycle of hormonal imbalance.

Metabolic and Systemic Implications

PCOS is not limited to reproductive issues—it has significant metabolic and systemic consequences:

1. Insulin Resistance and Hyperinsulinemia

  • Insulin resistance occurs in 60–80% of women with PCOS.
  • Hyperinsulinemia stimulates theca cell androgen production and contributes to obesity, type 2 diabetes, metabolic syndrome, and dyslipidemia.

2. Cardiovascular Risk

  • Chronic insulin resistance and androgen excess increase cardiovascular risk, including hypertension, atherosclerosis, and endothelial dysfunction.

3. Endometrial Hyperplasia and Cancer Risk

  • Chronic anovulation leads to unopposed estrogen, which stimulates the endometrium continuously.
  • This may result in endometrial hyperplasia, irregular bleeding, and an increased risk of endometrial cancer if untreated.
  • For a broader understanding of how cancer develops and its risk factors, you can read What is Cancer?

Lifestyle and Dietary Approaches for PCOS

Lifestyle management is considered a first-line therapy for PCOS, particularly for addressing insulin resistance, metabolic complications, and hormonal imbalances. Small, consistent changes in weight, diet, and physical activity can significantly improve symptoms, restore ovulation, and enhance overall health.

For a comprehensive guide on managing stress and enhancing mental wellness—which are crucial aspects of PCOS management—read our article on Powerful Stress & Mental Wellness 2025.

1. Weight Reduction

Maintaining a healthy weight is crucial for women with PCOS because even modest weight loss can improve hormonal balance.

Benefits of Weight Reduction

  • Losing 5–10% of body weight can restore ovulation in many women.
  • Reduces insulin resistance, which helps lower circulating androgens and improves menstrual regularity.
  • Decreases the risk of type 2 diabetes, metabolic syndrome, and cardiovascular disease.

Practical Tips for Weight Management

  • Track calorie intake using a food diary or mobile app.
  • Incorporate portion control and mindful eating practices.
  • Focus on gradual, sustainable weight loss rather than rapid dieting, which can worsen hormonal imbalance.

2. Diet Management

A balanced diet tailored for PCOS can improve insulin sensitivity, reduce inflammation, and support hormone regulation.

Key Dietary Strategies

  • Emphasize low-glycemic index (GI) foods such as whole grains, legumes, vegetables, and fruits to stabilize blood sugar levels.
  • Include lean proteins (chicken, fish, tofu, eggs) to support satiety and muscle maintenance.
  • Consume healthy fats like olive oil, nuts, seeds, and avocado, which help reduce inflammation and improve cardiovascular health.
  • Increase dietary fiber intake to improve digestion and reduce insulin spikes.

Foods to Limit

  • Refined sugars and processed foods, which raise blood glucose and worsen insulin resistance.
  • High saturated fat intake, which can contribute to weight gain and inflammation.

3. Exercise

Regular physical activity plays a critical role in managing PCOS by enhancing insulin sensitivity, reducing androgen levels, and promoting reproductive health.

Recommended Exercise Routine

  • Aerobic exercises: Walking, jogging, swimming, or cycling for at least 150 minutes per week.
  • Resistance training: Weightlifting, bodyweight exercises, or resistance bands 2–3 times per week to build lean muscle and boost metabolism.
  • Flexibility and stress reduction: Yoga and stretching can help reduce stress, which may improve hormonal balance.

Additional Benefits of Exercise

  • Reduces central obesity and visceral fat, which improves metabolic function.
  • Enhances mood and mental health, helping combat anxiety and depression commonly associated with PCOS.
  • Supports long-term weight management and cardiovascular health.

4. Holistic Approach

Combining weight management, diet, and exercise provides the best outcomes for women with PCOS. Even small lifestyle changes—such as walking daily, replacing sugary snacks with nuts, or adding resistance training twice a week—can make a significant difference.

Additionally, tracking progress through menstrual cycle monitoring, blood sugar levels, and regular medical check-ups can help women with PCOS stay on track and adjust strategies for optimal results.

For more tips on maintaining mental wellness while managing PCOS, check out our detailed guide on Powerful Stress & Mental Wellness 2025.

Pharmacological Interventions for PCOS

Pharmacological therapy is often used alongside lifestyle interventions to manage symptoms, restore hormonal balance, and improve fertility in women with PCOS. The choice of medication depends on primary concerns, such as irregular periods, hyperandrogenism, insulin resistance, or infertility.

1. Oral Contraceptives

Oral contraceptives (combined estrogen-progestin pills) are commonly prescribed to:

  • Regulate menstrual cycles, especially in women with irregular periods or amenorrhea.
  • Reduce hyperandrogenism, which helps alleviate hirsutism, acne, and androgenic alopecia.
  • Lower the risk of endometrial hyperplasia by counteracting unopposed estrogen in chronic anovulation.

2. Anti-Androgens

Anti-androgen medications target excess androgen effects:

  • Spironolactone: Blocks androgen receptors, reducing hirsutism and acne.
  • Flutamide: Potent anti-androgen that decreases facial and body hair growth.
  • Finasteride: Inhibits conversion of testosterone to dihydrotestosterone (DHT), helping with hair loss and acne.

Note: Anti-androgens should be combined with effective contraception as they can cause fetal abnormalities during pregnancy.

3. Insulin Sensitizers

Insulin-sensitizing agents are essential for women with insulin resistance or metabolic complications:

  • Metformin: Improves insulin sensitivity, lowers circulating insulin, and may restore ovulation.
  • Thiazolidinediones (e.g., pioglitazone): Improve insulin action in peripheral tissues and reduce androgen production.

Benefits include better glycemic control, reduced androgen levels, and improved menstrual regularity.

4. Ovulation Induction

For women with PCOS struggling with infertility, medications that induce ovulation are used:

  • Clomiphene citrate: First-line therapy; stimulates ovulation by increasing FSH levels.
  • Letrozole: Aromatase inhibitor that enhances ovulation, increasingly preferred for PCOS-related infertility.
  • Gonadotropins: Injectable hormones used when oral medications fail, often under strict medical supervision due to risk of multiple pregnancies.

These treatments aim to restore fertility while minimizing the risks of ovarian hyperstimulation and multiple gestations.

Pharmacological interventions in PCOS are most effective when combined with diet, exercise, and stress management, providing a holistic approach to managing both reproductive and metabolic aspects of the syndrome.

FAQs on PCOS

Q1. What is the first sign of Polycystic Ovarian Disease?
Irregular or missed menstrual periods are often the earliest and most noticeable symptom of Polycystic Ovarian Disease. Some women may also notice unexplained weight gain, acne, or excessive hair growth during this stage.

Q2. Can PCOS cause infertility?
Yes, PCOS can lead to chronic anovulation, where eggs are not released regularly. This makes it difficult for women to conceive naturally. However, with lifestyle changes and medical treatments, many women with PCOS can achieve pregnancy.

Q3. Is PCOS the same as PCOD?
No, PCOD (Polycystic Ovarian Disease) is generally considered milder and involves ovarian cysts without significant hormonal or metabolic complications. PCOS, on the other hand, includes hormonal imbalances, insulin resistance, and a higher risk of metabolic disorders.

Q4. Can lifestyle changes alone manage PCOS?
In mild cases, weight reduction, a balanced diet, and regular exercise can significantly improve symptoms, restore ovulation, and reduce androgen levels. However, more severe cases may require medications alongside lifestyle interventions.

Q5. Does PCOS increase the risk of diabetes?
Yes, insulin resistance, a common feature of PCOS, raises the risk of type 2 diabetes, metabolic syndrome, and cardiovascular complications. Regular monitoring of blood sugar levels and maintaining a healthy lifestyle can help reduce these risks.

Conclusion

Polycystic Ovary Syndrome (PCOS) is a complex, multifactorial disorder that affects reproductive, metabolic, and hormonal health in women. Early recognition through clinical signs, biochemical tests, and ultrasound findings is essential for effective management. Combining lifestyle interventions, pharmacological treatments, and fertility therapies offers the best outcomes, improving hormonal balance, metabolic health, and overall quality of life.

Individualized care is key, as each woman may experience different symptoms and complications. Addressing PCOS holistically, including mental wellness and stress management, can help reduce long-term risks such as diabetes, cardiovascular disease, and infertility.

Disclaimer

This content is provided for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment, or personalized guidance regarding PCOS.

e4d19e5e040a83ec15cad1e5a05ac411

Neeraj Kumar Verma

Mr. Neeraj Kumar Verma is the passionate mind behind Pharmacy Professor. As an Assistant Professor at Shri Ramswaroop Memorial University, he specializes in Pharmaceutics and enjoys sharing knowledge with students and readers alike.He is a Pharmacy Educator who runs the website and YouTube channel Pharmacy Professor, helping students with pharmacy education, GPAT, pharmacy-related exams, handwritten notes, M.Pharm & PhD research, theses, and research papers.

Leave a comment